Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

被引：15

作者：

Mingot-Castellano, Maria Eva ^{[1
]}

Canaro Hirnyk, Mariana ^{[2
]}

Sanchez-Gonzalez, Blanca ^{[3
]}

Alvarez-Roman, Maria Teresa ^{[4
]}

Barez-Garcia, Abelardo ^{[5
]}

Bernardo-Gutierrez, Angel ^{[6
]}

Bernat-Pablo, Silvia ^{[7
]}

Bolanos-Calderon, Estefania ^{[8
]}

Butta-Coll, Nora ^{[9
]}

Caballero-Navarro, Gonzalo ^{[10
]}

Caparros-Miranda, Isabel Socorro ^{[11
]}

Entrena-Urena, Laura ^{[12
]}

Fernandez-Fuertes, Luis Fernando ^{[13
]}

Garcia-Frade, Luis Javier ^{[14
]}

Gomez del Castillo, Maria del Carmen ^{[15
]}

Gonzalez-Lopez, Tomas Jose ^{[16
]}

Grande-Garcia, Carlos ^{[17
]}

Guinea de Castro, Jose Maria ^{[18
]}

Jarque-Ramos, Isidro ^{[19
]}

Jimenez-Barcenas, Reyes ^{[20
]}

Lopez-Ansoar, Elsa ^{[21
]}

Martinez-Carballeira, Daniel ^{[6
]}

Martinez-Robles, Violeta ^{[22
]}

Monteagudo-Montesinos, Emilio ^{[23
]}

Paramo-Fernandez, Jose Antonio ^{[24
]}

Perera-alvarez, Maria del Mar ^{[25
]}

Soto-Ortega, Inmaculada ^{[6
]}

Valcarcel-Ferreiras, David ^{[26
]}

Pascual-Izquierdo, Cristina ^{[27
,28
]}

机构：

[1] Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Dept Hematol, Seville 41013, Spain

[2] Hosp Son Espases, Dept Hematol, Palma De Mallorca 07210, Palma, Spain

[3] Hosp Mar, Dept Hematol, Barcelona 08003, Spain

[4] Univ Autonoma Madrid, Hosp Univ La Paz IdiPAZ, Dept Hematol, Madrid 28046, Spain

[5] Hosp Avila, Dept Hematol, Avila 05004, Spain

[6] Hosp Cent Asturias, Dept Hematol, Oviedo 33011, Spain

[7] Hosp Univ Plana, Dept Hematol, Villarreal 12540, Spain

[8] Hosp Clin San Carlos, Dept Hematol, IML, IdISSC, Madrid 28040, Spain

[9] Inst Investigac Hosp Univ La Paz IdiPAZ, Dept Hematol, Madrid 28046, Spain

[10] Hosp Univ Miguel Servet, Dept Hematol, Zaragoza 50009, Spain

[11] Hosp Univ Virgen Victoria, Dept Hematol, Malaga 29010, Spain

[12] Hosp Univ Virgen Nieves, Dept Hematol, Granada 18014, Spain

[13] Complejo Hosp Univ Insular Materno Infant, Dept Hematol, Las Palmas Gran Canaria 35016, Spain

[14] Hosp Univ Rio Hortega, Dept Hematol, Gerencia Reg Salud Castilla & Leon, Valladolid 47012, Spain

[15] Hosp Gen Coruna, Dept Hematol, La Coruna 15006, Spain

[16] Hosp Univ Burgos, Dept Hematol, Burgos 09006, Spain

[17] Univ Navarra Clin, Dept Hematol, Madrid 28022, Spain

[18] Hosp Univ Araba, Dept Hematol, Vitoria 01009, Spain

[19] Hosp Univ Politecn Le Fe, Dept Hematol, Valencia 46026, Spain

[20] Hosp Serrania Ronda, Dept Hematol, Ronda 29400, Spain

[21] Complejo Hosp Univ Vigo, Dept Hematol, Vigo 36312, Spain

[22] Complejo Asistencial Univ Leon, Dept Hematol, Leon 24008, Spain

[23] Hosp Univ Politecn Le Fe, Dept Pediat, Valencia 46026, Spain

[24] Univ Navarra Clin, Dept Hematol, Pamplona 31008, Spain

[25] Hosp Univ Gran Canaria Doctor Negrin, Dept Hematol, Las Palmas Gran Canaria 35010, Spain

[26] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Dept Hematol, Barcelona 08035, Spain

[27] Hosp Gen Univ Gregorio Maranon HGUGM Madrid, Inst Invest Gregorio Maranon, Dept Hematol, Madrid 28007, Spain

[28] Spanish Immune Thrombocytopenia Grp, Madrid 28040, Spain

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 20期

关键词：

primary immune thrombocytopenia; glucocorticoids; intravenous immunoglobulins; fostamatinib; rituximab; recommendations; THROMBOPOIETIN-RECEPTOR AGONISTS; HIGH-DOSE DEXAMETHASONE; LONG-TERM; PYLORI INFECTION; SINGLE-CENTER; FOLLOW-UP; RITUXIMAB; ELTROMBOPAG; MANAGEMENT; EFFICACY;

D O I：

10.3390/jcm12206422

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.

引用

页数：29

共 138 条

[61] Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision
Kashiwagi, Hirokazu
Kuwana, Masataka
Hato, Takaaki
Takafuta, Toshiro
Fujimura, Kingo
Kurata, Yoshiyuki
Murata, Mitsuru
Tomiyama, Yoshiaki
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (03) : 329 - 351
[62] Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Khellaf, Mehdi
Charles-Nelson, Anais
Fain, Olivier
Terriou, Louis
Viallard, Jean-Francois
Cheze, Stephane
Graveleau, Julie
Slama, Borhane
Audia, Sylvain
Ebbo, Mikael
Le Guenno, Guillaume
Cliquennois, Manuel
Salles, Gilles
Bonmati, Caroline
Teillet, France
Galicier, Lionel
Hot, Arnaud
Lambotte, Olivier
Lefrere, Francois
Sacko, Salimatou
Kengue, Dieudonne Kilendo
Bierling, Philippe
Roudot-Thoraval, Francoise
Michel, Marc
Godeau, Bertrand
[J]. BLOOD, 2014, 124 (22) : 3228 - 3236
[63] Dapsone: An Old but Effective Therapy in Pediatric Refractory Immune Thrombocytopenia
Khera, Sanjeev
Pramanik, Suman Kumar
Yanamandra, Uday
Mishra, Kundan
Kapoor, Rajan
Das, Satyaranjan
[J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (04) : 690 - 694
[64] Primary and Secondary Immune Cytopenias Evaluation and Treatment Approach in Children
Kim, Taylor Olmsted
Despotovic, Jenny M.
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (03) : 489 - +
[65] Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
Kuter, David J.
Bussel, James B.
Newland, Adrian
Baker, Ross I.
Lyons, Roger M.
Wasser, Jeffrey
Viallard, Jean-Francois
Macik, Gail
Rummel, Mathias
Nie, Kun
Jun, Susie
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 411 - 423
[66] Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
Kuter, David J.
Rummel, Mathias
Boccia, Ralph
Macik, B. Gail
Pabinger, Ingrid
Selleslag, Dominik
Rodeghiero, Francesco
Chong, Beng H.
Wang, Xuena
Berger, Dietmar P.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) : 1889 - 1899
[67] Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience
Lapietra, Gianfranco
Ferretti, Antonietta
Baldacci, Erminia
Chistolini, Antonio
Santoro, Cristina
[J]. EJHAEM, 2022, 3 (02): : 453 - 456
[68] Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study
Le Guenno, Guillaume
Guieze, Romain
Audia, Sylvain
Khellaf, Mehdi
Michel, Marc
Bonnotte, Bernard
Ruivard, Marc
Godeau, Bertrand
[J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (09) : 1154 - 1162
[69] Li Y, 2015, EUR REV MED PHARMACO, V19, P1583
[70] The efficacy and safety of low-dose rituximab in immune thrombocytopenia: a systematic review and meta-analysis
Li, Yunjie
Shi, Yuye
He, Zhengmei
Chen, Qiuni
Liu, Zhenyou
Yu, Liang
Wang, Chunling
[J]. PLATELETS, 2019, 30 (06) : 690 - 697

← 2 3 4 5 6 7 8 9 10 11 →